Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver regeneration versus direct hyperplasia

A Columbano1, H Shinozuka

  • 1Istituto di Patologia Sperimentale, University of Cagliari, Italy.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|August 1, 1996
PubMed
Summary

Liver regeneration and direct hyperplasia exhibit distinct molecular pathways. Understanding these differences in liver cell proliferation is crucial for cancer research and potential therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.

Oncogene·2012
Same author

Promoting activities of the C-9 oxidized metabolites of N-2-fluorenylacetamide in liver carcinogenesis in the rat.

International journal of oncology·2011
Same author

The TRbeta-selective agonist, GC-1, stimulates mitochondrial oxidative processes to a lesser extent than triiodothyronine.

The Journal of endocrinology·2010
Same author

T3 and the thyroid hormone beta-receptor agonist GC-1 differentially affect metabolic capacity and oxidative damage in rat tissues.

The Journal of experimental biology·2009
Same author

Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration.

Cell proliferation·2008
Same author

14th Euroconference on Apoptosis: 'death or survival? Fate in Sardinia'.

Cell death and differentiation·2007

Area of Science:

  • Hepatology
  • Molecular Biology
  • Carcinogenesis

Background:

  • Liver cell growth occurs via compensatory regeneration (post-cell loss) or direct hyperplasia (without cell loss).
  • Molecular mechanisms of compensatory regeneration are increasingly understood, involving specific transcription factors and growth factors.

Purpose of the Study:

  • To investigate the distinct molecular signaling pathways of compensatory liver regeneration versus direct hyperplasia induced by primary mitogens.
  • To compare the roles of growth factors and signal transduction in these two liver cell proliferation patterns.
  • To explore the implications of these differences on chemical hepatocarcinogenesis initiation and promotion.

Main Methods:

  • Comparative analysis of molecular events, including transcription factor activation (e.g., NF-kappa B) and immediate early gene expression (e.g., c-fos, c-jun).

Related Experiment Videos

  • Evaluation of the role of specific growth factors (e.g., hepatocyte growth factor, transforming growth factor-alpha) in hepatocyte cell cycle progression.
  • Investigation of signaling pathways triggered by primary mitogens, potentially involving tumor necrosis factor-alpha or nuclear hormone receptors.

    • Main Results:

    • Compensatory regeneration involves NF-kappa B activation and immediate early gene induction, unlike direct hyperplasia.
    • Key growth factors like HGF and TGF-alpha are critical for compensatory regeneration but not direct hyperplasia.
    • Primary mitogens may signal through tumor necrosis factor-alpha or nuclear hormone receptors.

    Conclusions:

    • Liver regeneration and direct hyperplasia utilize different molecular mechanisms for hepatocyte proliferation.
    • These mechanistic differences influence the initiation of chemical hepatocarcinogenesis, with regeneration supporting it and hyperplasia not.
    • Understanding these pathways could lead to clinical applications in liver gene transfer and transplantation due to the low toxicity of primary liver mitogens.